IL6 and hydrops fetalis: In one meta-analysis of randomized controlled trials with carvedilol, Tatli et al. reported reductions in plasma TNF-alpha, IL-2 and IL-6 accompanied by improvements in EF and HF severity in patients with dilated cardiomyopathy [71].